Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

Delayed Quote. Delayed  - 05/31 03:40:42 pm
2.3 CHF   -0.86%
05/30 ADDEX THERAPEUT : Increases Issued Share Capital and Creates Treasur..
04/29 ADDEX THERAPEUT : Reports 2015 Financial Results
04/29 ADDEX THERAPEUT : Reports 2015 Financial Results
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
05/25/2016 05/26/2016 05/27/2016 05/30/2016 05/31/2016 Date
2.34(c) 2.33(c) 2.4(c) 2.32(c) 2.3 Last
33 854 3 776 2 002 27 867 18 947 Volume
+1.74% -0.43% +3.00% -3.33% -0.86% Change
More quotes
Company
Addex Therapeutics Ltd. engages in the discovery and development of oral small molecule drugs.The company uses its proprietary discovery platform to address receptors and other proteins that are undruggable for conventional drug discovery methods, including G-protein coupled receptors, receptor... 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
05/30 ADDEX THERAPEUTICS : Increases Issued Share Capital and Creates Treasury Shares
04/29 ADDEX THERAPEUTICS : Reports 2015 Financial Results
04/29 ADDEX THERAPEUTICS : Reports 2015 Financial Results
04/11 ADDEX THERAPEUTICS : Reports Positive Results of an mGlu5 Receptor Occupancy Stu..
03/15 ADDEX THERAPEUTICS : Reports Successful Completion of an mGlu5 Receptor Occupanc..
01/11 ADDEX THERAPEUTICS : Dipraglurant Shows Highly Statistically Significant Anti-Dy..
01/04 ADDEX THERAPEUTICS : ' Dipraglurant Receives Orphan Drug Designation from the FD..
2015 ADDEX THERAPEUTICS : Reports Statistically Significant Positive Interim Data for..
2015 ADDEX THERAPEUTICS : and University of Geneva Collaborators Awarded Swiss Grant ..
2015 ADDEX THERAPEUTICS : Scientists Publish New Data Supporting the Potential of mGl..
More news
Sector news : Biotechnology & Medical Research - NEC
03:18a GENMAB A/S : to Present at the Goldman Sachs 37th Annual Global Healthcare Confe..
05/30 Genmab Achieves USD 30 Million Milestone in DARZALEX(r) (daratumumab) Collabo..
05/30 GENMAB A/S : Achieves USD 30 Million Milestone in DARZALEX® (daratumumab) Collab..
05/30 Samsung Bioepis receives final European approval for its Remicade copy
05/27 AMGEN : receives positive CHMP opinion to extend indication of Kyprolis
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Full-screen chart
Technical analysis trends ADDEX THERAPEUTIC...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials